Exothera
Solène Arnoult is a Bioprocess Engineer at EXOTHERA since May 2020, specializing in upstream process development for the exoREADY™ platform, which produces multiple serotypes of adeno-associated virus (AAV). Previously, Solène held positions as a Junior Bioprocess Engineer at EXOTHERA and UNIVERCELLS, focusing on the production of viral vectors and biosimilars, respectively. Early experience includes an internship at UCB, where Solène contributed to monoclonal antibody development and metabolite quantification. Academic qualifications include a Master of Science in Biotechnology Engineering from Polytech Marseille and a diploma in experimental design and statistical analysis from Aix-Marseille University. Additionally, Solène has engaged in research internships studying potential cervical cancer biomarkers and has exposure to recombinant antibody production processes.
Exothera
Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660